Project Grant R21DA064465
Award Date 9/15/25
Completion Date 8/31/27
Dollars Obligated $233K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- This Project Grant award of $783,300 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research study titled "Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV (STRONG)". The study will be conducted by The Johns Hopkins University in Maryland and aims to comprehensively characterize opioid use disorder (OUD) treatment, co-occurring substance use and...
- This $4.9 million project grant from the National Institutes of Health's National Institute on Drug Abuse will support research at The Johns Hopkins University from April 2022 to March 2026. The grant is part of the Drug Abuse and Addiction Research Programs (CFDA 93.279), which aims to develop new knowledge around prevention, diagnosis, treatment and causes of drug abuse and addiction. Specifically, the university will leverage rare longitudinal social and spatial network data along with...
- The federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $439,180 to The Johns Hopkins University to investigate the role of dopaminergic neuron-glial interactions in the striatum in the context of HIV infection and substance use disorders. The research aims to deconvolute the complex interplay between HIV, methamphetamine use, and alterations in dopamine signaling pathways, which can contribute...
- The Johns Hopkins University was awarded a $634,617 project grant from the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs) on July 15, 2025. The grant will support research to understand the neural basis of the transition from goal-directed to habitual behavior, which is thought to rely on a shift in control from the dorsomedial to dorsolateral striatum. The research project aims to leverage a novel behavioral paradigm called "volitional...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a 5-year, $1,546,730 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to support the continuation and expansion of the Johns Hopkins HIV Implementation Science Hub (Hopkins Hub). The key objectives of this award are to: 1) enhance the technical rigor of implementation science research and build capacity among investigators focused on ending...
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the effects of opioids on HIV transcription and latency. The $234,000 award to Georgetown University will support research using a novel dual fluorescent and bioluminescent virus called EcoHIV NL4-3 Dual Red to visualize active HIV proviral transcription in microglia and astrocytes. The study will examine the mechanisms by which...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- The Johns Hopkins University was awarded a $672,248 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) to study sex-specific features of the HIV reservoir and immune responses across the female reproductive lifespan in a cohort of Ugandans living with HIV. The 5-year project, which began on September 15, 2025, aims to: 1) analyze the impact of pregnancy on HIV reservoir and immunity, 2) assess HIV reservoir and...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) provides $699,911 in funding to The Johns Hopkins University to conduct a Randomized Clinical Trial of a Peer Education Intervention to Promote Social Diffusion of Overdose Prevention and Drug Use Cessation in High Burden Communities. The project period is from Sep 30, 2025 to Sep 29, 2030. The goal of the research is...
- This federal Project Grant award of $1,210,300 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of novel polyvalent HIV vaccines to protect people who inject drugs (PWID) against intravenous HIV transmission. The project aims to create a vaccine that can elicit high levels of immune responses to rapidly clear multiple HIV strains that may be transmitted through needle use. The grant was awarded to Beth...